BioDelivery Sciences Reports Mixed Q2 Earnings, Sees FY21 Belbuca Sales At Lower End Of Guidance Range

By: via Benzinga
BioDelivery Sciences International Inc(NASDAQ: BDSI) hasreported Q2 sales of $41.4 million, + 13.3% Y/Y, missing the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.